Atractylenolide III
CAS No. 73030-71-4
Atractylenolide III ( ICodonolactone; 8β-Hydroxyasterolide )
Catalog No. M19046 CAS No. 73030-71-4
Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 56 | In Stock |
|
5MG | 101 | In Stock |
|
10MG | 182 | In Stock |
|
25MG | 328 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtractylenolide III
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.
-
DescriptionAtractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung carcinoma by inducing the release of cytochrome c, upregulating the expression of Bax and translocating apoptosis-inducing factor.
-
SynonymsICodonolactone; 8β-Hydroxyasterolide
-
PathwayOthers
-
TargetOther Targets
-
RecptorApoptosis inducer
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number73030-71-4
-
Formula Weight248.32
-
Molecular FormulaC15H20O3
-
Purity98%
-
SolubilityDMSO : ≥ 100 mg/mL; 402.71 mM
-
SMILESC=C1CCC[C@]2([C@H]1CC1=C(C)C(=O)O[C@]1(C2)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhao H,et al. Neuroscience. 2015 Apr 2;290:485-91.
molnova catalog
related products
-
Mc-Val-Cit-PAB-Cl
Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE.
-
Peucedanocoumarin II
Peucedanocoumarin II shows only partial relaxation.
-
BPH-1358
BPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor.